Mode
Text Size
Log in / Sign up

Elevated glucose, chloride, and anion gap levels are associated with increased risk of acute kidney injurySpecific Biomarkers Linked to Higher Risk of Kidney Injury

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that elevated glucose, chloride, and anion gap are associated with increased risk of acute kidney injury.

This meta-analysis analyzed data from 785,497 adult inpatients across 9 U.S. academic medical centers to identify biomarker associations with acute kidney injury. The study focused on identifying risk drivers and biomarker interactions to improve risk stratification in hospital settings.

Key findings indicate that an increase in glucose from 100 mg/dL to 140 mg/dL is associated with a 1.46-fold higher risk of acute kidney injury. Additionally, a chloride increase across 96-100 mEq/L was associated with a 1.28-fold increase in risk, while an anion gap increase across 4-12 mmol/L was associated with a 1.14-fold increase in risk. The analysis also identified quadratic associations for potassium, calcium, and sodium.

The study notes that these findings are associations identified through machine learning models and do not establish direct causation. These biomarkers may offer value in identifying specific risk drivers to enhance personalized prevention strategies in hospital care. No specific limitations were reported in the source data.

Researchers analyzed data from nearly 800,000 adult patients across nine U.S. medical centers to identify risk factors for acute kidney injury. The study looked at how various blood markers, such as glucose, chloride, and potassium, relate to the risk of kidney damage during hospital stays.

The findings showed that certain levels of these markers are linked to higher risks. For example, an increase in glucose from 100 mg/dL to 140 mg/dL was associated with a 1.46-fold higher risk of kidney injury. Similarly, higher chloride levels and a larger anion gap were also linked to increased risk.

It is important to note that these results show a link between blood levels and kidney health, but they do not prove that the blood levels cause the injury. Because this study used machine learning models to find these patterns, the results are intended to help doctors better identify which patients might need more personalized care and prevention.

What this means for you:
Specific blood markers like glucose and chloride are linked to higher risks of acute kidney injury in hospital patients.

Common questions

What blood markers are linked to kidney injury?

The study identified several markers, including glucose, chloride, anion gap, potassium, calcium, and sodium. Specifically, an increase in glucose from 100 mg/dL to 140 mg/dL was linked to a 1.46-fold higher risk of acute kidney injury. Chloride levels and anion gap also showed links to increased risk.

Does high blood sugar cause kidney damage?

The study shows a link between higher glucose levels and an increased risk of acute kidney injury, but it does not prove that the glucose causes the injury. These findings are intended to help doctors better identify patients who may need extra monitoring or personalized prevention.

Who was included in this study?

The study included a very large group of 785,497 adult inpatients. The data was collected from nine U.S. academic medical centers to help identify risk drivers and improve how doctors provide care for patients with potential kidney issues.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
Background: Current understanding of acute kidney injury (AKI) risk factors remains largely descriptive, offering limited precision into how specific biomarker values or physiologic thresholds influence susceptibility. We aimed to synthesize knowledge from machine learning models trained across multiple health systems to identify generalizable, value-specific risk drivers and biomarker interactions contributing to AKI risk. Methods: We analyzed electronic health records (EHRs) from 785,497 adult inpatients between 2010 and 2019 across nine U.S. academic medical centers within PCORnet. Interpretable gradient boosting machine models were independently developed at each health system to quantify predictor-outcome associations. Meta-regression was applied to integrate these site-level results, characterize nonlinear value-risk relationships, and identify bivariate interactions between predictors. Results: Meta-analysis revealed consistent, value-specific risk drivers across health systems. An increase in glucose from 100 mg/dL to 140 mg/dL was associated with a 1.46-fold higher risk of AKI. Chloride and anion gap also demonstrated elevated AKI risk with risk increases overlapping portions of their reference ranges, with anion gap showing a 1.14-fold increase across 4-12 mmol/L and chloride a 1.28-fold increase across 96-100 mEq/L. Electrolytes including potassium, calcium, and sodium showed quadratic associations with AKI risk. Bivariate meta-regression identified interactions between key predictors, highlighting pathways that jointly modulate AKI risk. Conclusion: This cross-system meta-analysis synthesizes machine learning-derived evidence into clinically interpretable knowledge, revealing how specific biomarker ranges and interactions modulate AKI risk. By moving beyond surface-level associations to quantitative, generalizable physiologic thresholds, these findings provide actionable insights to enhance risk stratification and personalized prevention in hospital care.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.